Enliven
ELVNEnliven Therapeutics, Inc. Price (ELVN)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
47,072,532
(32.4263)%Balance Sheet Summary
| Total Assest | |
| Total Liabilities | |
| Total Equity | |
| Total Investments | |
| Total Liabilities And Total Equ... | |
| Total debt |
Balance Sheet
Enliven Therapeutics, Inc.Currency: USD
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current Assets | |||||||||||||||||||
| Cash And Cash Equivalents | 9.67M | 7.38M | 4.94M | 130.37M | 110.02M | 75.54M | 100.14M | 124.12M | |||||||||||
| Short Term Investments | 0.00 | 0.00 | 23.97M | 40.52M | 41.97M | 0.00 | 153.01M | 189.32M | |||||||||||
| Net Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Other Current Assets | 552.00k | 323.00k | 1.72M | 222.00k | 646.00k | 2.22M | 13.00M | 4.69M | |||||||||||
| Total Current Assets | 10.22M | 7.71M | 30.62M | 130.59M | 110.67M | 77.75M | 266.15M | 318.13M | |||||||||||
| Non Current Assets | |||||||||||||||||||
| Property, Plant, and Equipment, Net | 0.00 | 0.00 | 442.00k | 416.00k | 954.00k | 1.52M | 1.06M | 458.00k | |||||||||||
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Long Term Investments | 0.00 | 0.00 | 88.00k | 88.00k | 175.00k | 54.00k | 0.00 | 0.00 | |||||||||||
| Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Other Non-Current Assets | 0.00 | 0.00 | 2.14M | -88,000.00 | 1.53M | 3.98M | 4.65M | 7.18M | |||||||||||
| Total Non-Current Assets | 0.00 | 0.00 | 2.67M | 416.00k | 2.66M | 5.55M | 5.72M | 7.63M | |||||||||||
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Total Assets | 10.22M
+0% |
7.71M
-25% |
33.30M
+332% |
131.00M
+293% |
113.33M
-13% |
83.30M
-26% |
271.87M
+226% |
325.76M
+20% |
|||||||||||
| Liabilities | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Account Payables | 431.00k | 908.00k | 1.66M | 808.00k | 2.52M | 3.44M | 532.00k | 1.34M | |||||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 105.00k | 159.00k | 323.00k | 335.00k | 0.00 | |||||||||||
| Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Deferred Revenue | 0.00 | 0.00 | 0.00 | 429.00k | 2.70M | 5.51M | 0.00 | 0.00 | |||||||||||
| Other Current Liabilities | 395.00k | 924.00k | 2.54M | 565.00k | 3.07M | 5.95M | 25.03M | 14.57M | |||||||||||
| Total Current Liabilities | 826.00k | 1.83M | 4.20M | 1.48M | 5.75M | 9.72M | 25.89M | 15.92M | |||||||||||
| Non Current Liabilities | |||||||||||||||||||
| Long Term Debt | 660.00k | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Deferred Tax Liabilities Non-Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Other Non-Current Liabilities | 0.00 | 32.19M | 184.00k | 149.83M | 150.46M | 150.41M | 67.00k | 0.00 | |||||||||||
| Total Non-Current Liabilities | 660.00k | 32.19M | 184.00k | 149.83M | 150.46M | 150.41M | 67.00k | 0.00 | |||||||||||
| Other Liabilities | 0.00 | -32,189,000.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Capital Lease Obligations | 0.00 | 0.00 | 0.00 | 105.00k | 159.00k | 323.00k | 335.00k | 0.00 | |||||||||||
| Total Liabilities | 1.49M
+0% |
1.83M
+23% |
4.38M
+139% |
151.31M
+3,353% |
156.22M
+3% |
160.12M
+3% |
25.96M
-84% |
15.92M
-39% |
|||||||||||
| Equity | |||||||||||||||||||
| Preferred Stock | 0.00 | 0.00 | 0.00 | 149.75k | 149.75k | 149.75k | 0.00 | 0.00 | |||||||||||
| Common Stock | 4.00k | 4.00k | 4.00k | 1,000.00 | 1,000.00 | 1,000.00 | 41.00k | 49.00k | |||||||||||
| Retained Earnings | -19,953,000.00 | -31,290,000.00 | -54,753,000.00 | -20,462,000.00 | -45,202,000.00 | -82,864,000.00 | -154,448,000.00 | -243,472,000.00 | |||||||||||
| Accumulated Other Comprehensive Income Loss | 0.00 | 0.00 | 32.00k | 4.00k | -16,000.00 | -149,749.00 | 141.00k | 55.00k | |||||||||||
| Other Total Stockholders Equity | 4.42M | 4.97M | 5.87M | 157.00k | 2.33M | 6.19M | 400.17M | 553.21M | |||||||||||
| Total Stockholders Equity | -15,534,000.00 | -26,316,000.00 | -48,848,000.00 | -20,304,000.00 | -42,887,000.00 | -76,825,000.00 | 245.91M | 309.85M | |||||||||||
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Total Equity | -15,534,000.00
+0% |
-26,316,000.00
+69% |
-48,848,000.00
+86% |
-20,304,000.00
-58% |
-42,887,000.00
+111% |
-76,825,000.00
+79% |
245.91M
-420% |
309.85M
+26% |
|||||||||||
| Total Liabilities And Total Equity | 10.22M
+0% |
7.71M
-25% |
33.30M
+332% |
131.00M
+293% |
113.33M
-13% |
83.30M
-26% |
271.87M
+226% |
325.76M
+20% |
|||||||||||
| Additional Metrics | |||||||||||||||||||
| Total Investments | 0.00
+0% |
0.00
+0% |
24.06M
+0% |
40.61M
+69% |
42.14M
+4% |
54.00k
-100% |
153.01M
+283,246% |
189.32M
+24% |
|||||||||||
| Total Debt | 660.00k
+0% |
0.00
+0% |
0.00
+0% |
105.00k
+0% |
159.00k
+51% |
323.00k
+103% |
335.00k
+4% |
0.00
+0% |
|||||||||||
| Net Debt | -9,011,000.00 | -7,382,000.00 | -4,936,000.00 | -130,260,000.00 | -109,865,000.00 | -75,213,000.00 | -99,806,000.00 | -124,117,000.00 | |||||||||||